{"id":"https://openalex.org/W7017744282","doi":null,"title":"On cardiovascular complications in people with type 2 diabetes : Aspects of incretin-based therapy and glycemic control","display_name":"On cardiovascular complications in people with type 2 diabetes : Aspects of incretin-based therapy and glycemic control","alternate_titles":[],"publication_year":2024,"publication_date":"2024-01-15","ids":{"openalex":"https://openalex.org/W7017744282"},"language":"en","primary_location":{"id":"pmh:oai:openarchive.ki.se:10616/48957","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10616/48957","pdf_url":"https://openarchive.ki.se/articles/thesis/On_cardiovascular_complications_in_people_with_type_2_diabetes_Aspects_of_incretin-based_therapy_and_glycemic_control/26896360/1/files/48937444.pdf","source":{"id":"https://openalex.org/S4306400147","display_name":"Open Archive (Karolinska Institutet)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28166907","host_organization_name":"Karolinska Institutet","host_organization_lineage":["https://openalex.org/I28166907"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/doctoralThesis"},"parent_works":[],"lineage":["https://openalex.org/W7017744282"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://openarchive.ki.se/articles/thesis/On_cardiovascular_complications_in_people_with_type_2_diabetes_Aspects_of_incretin-based_therapy_and_glycemic_control/26896360/1/files/48937444.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090697793","display_name":"Irene Santos\u2010Pardo","orcid":"https://orcid.org/0000-0002-5933-7295","observed_orcids":["https://orcid.org/0000-0002-5933-7295"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210094988","display_name":"Stockholm South General Hospital","ror":"https://ror.org/00ncfk576","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210094988"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Irene Santos Pardo","raw_affiliation_strings":["Department of Clinical Science and Education, S\u00f6dersjukhuset, Karolinska Institutet"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Science and Education, S\u00f6dersjukhuset, Karolinska Institutet","institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5090697793"],"corresponding_institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cardiovascular-complications","display_name":"cardiovascular complications","score":0.9010000228881836},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9100000262260437},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9210000038146973},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9300000071525574},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9350000023841858},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.843999981880188},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8059999942779541},{"id":"https://openalex.org/keywords/in-stent-restenosis","display_name":"in-stent restenosis","score":0.7940000295639038},{"id":"https://openalex.org/keywords/stent-thrombosis","display_name":"stent thrombosis","score":0.9869999885559082},{"id":"https://openalex.org/keywords/drug-eluting-stents","display_name":"drug-eluting stents","score":0.9259999990463257},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9588000178337097},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6456999778747559},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6215999722480774},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5781000256538391},{"id":"https://openalex.org/C2778583881","wikidata":"https://www.wikidata.org/wiki/Q1325542","display_name":"Stent","level":2,"score":0.5242000222206116},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.4625000059604645},{"id":"https://openalex.org/C2778283817","wikidata":"https://www.wikidata.org/wiki/Q6590597","display_name":"Restenosis","level":3,"score":0.45660001039505005},{"id":"https://openalex.org/C2778213512","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary artery disease","level":2,"score":0.4521999955177307},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.439300000667572},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.42989999055862427},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.42739999294281006},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.3970000147819519},{"id":"https://openalex.org/C2779464278","wikidata":"https://www.wikidata.org/wiki/Q7317735","display_name":"Revascularization","level":3,"score":0.38519999384880066},{"id":"https://openalex.org/C2780911114","wikidata":"https://www.wikidata.org/wiki/Q14523941","display_name":"Coronary stent","level":4,"score":0.3643999993801117},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.364300012588501},{"id":"https://openalex.org/C2778095995","wikidata":"https://www.wikidata.org/wiki/Q17147174","display_name":"Neointimal hyperplasia","level":4,"score":0.3637000024318695},{"id":"https://openalex.org/C2777339539","wikidata":"https://www.wikidata.org/wiki/Q6993039","display_name":"Neointima","level":4,"score":0.36329999566078186},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.3418999910354614},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.3398999869823456},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.325300008058548},{"id":"https://openalex.org/C2780326628","wikidata":"https://www.wikidata.org/wiki/Q539795","display_name":"Angioplasty","level":2,"score":0.3190000057220459},{"id":"https://openalex.org/C2777546689","wikidata":"https://www.wikidata.org/wiki/Q3973120","display_name":"Drug-eluting stent","level":4,"score":0.30820000171661377},{"id":"https://openalex.org/C2777660278","wikidata":"https://www.wikidata.org/wiki/Q489997","display_name":"Diabetic angiopathy","level":3,"score":0.30550000071525574},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.29089999198913574},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.27950000762939453},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.26750001311302185},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.259799987077713},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.25609999895095825},{"id":"https://openalex.org/C2780036600","wikidata":"https://www.wikidata.org/wiki/Q415970","display_name":"Candesartan","level":4,"score":0.25060001015663147}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:openarchive.ki.se:10616/48957","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10616/48957","pdf_url":"https://openarchive.ki.se/articles/thesis/On_cardiovascular_complications_in_people_with_type_2_diabetes_Aspects_of_incretin-based_therapy_and_glycemic_control/26896360/1/files/48937444.pdf","source":{"id":"https://openalex.org/S4306400147","display_name":"Open Archive (Karolinska Institutet)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28166907","host_organization_name":"Karolinska Institutet","host_organization_lineage":["https://openalex.org/I28166907"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/doctoralThesis"},{"id":"pmh:oai:figshare.com:article/26896360","doi":null,"is_oa":false,"landing_page_url":"https://figshare.com/articles/thesis/On_cardiovascular_complications_in_people_with_type_2_diabetes_Aspects_of_incretin-based_therapy_and_glycemic_control/26896360","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis"}],"best_oa_location":{"id":"pmh:oai:openarchive.ki.se:10616/48957","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10616/48957","pdf_url":"https://openarchive.ki.se/articles/thesis/On_cardiovascular_complications_in_people_with_type_2_diabetes_Aspects_of_incretin-based_therapy_and_glycemic_control/26896360/1/files/48937444.pdf","source":{"id":"https://openalex.org/S4306400147","display_name":"Open Archive (Karolinska Institutet)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28166907","host_organization_name":"Karolinska Institutet","host_organization_lineage":["https://openalex.org/I28166907"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/doctoralThesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7017744282.pdf","grobid_xml":"https://content.openalex.org/works/W7017744282.grobid-xml"},"referenced_works_count":129,"referenced_works":["https://openalex.org/W125438606","https://openalex.org/W146325010","https://openalex.org/W176420385","https://openalex.org/W840965253","https://openalex.org/W1180976435","https://openalex.org/W1483874092","https://openalex.org/W1526927233","https://openalex.org/W1585758029","https://openalex.org/W1909310469","https://openalex.org/W1914420255","https://openalex.org/W1946152282","https://openalex.org/W1969759659","https://openalex.org/W1971428935","https://openalex.org/W1991372259","https://openalex.org/W1995209325","https://openalex.org/W1997808442","https://openalex.org/W2000976083","https://openalex.org/W2010000105","https://openalex.org/W2033598513","https://openalex.org/W2034318585","https://openalex.org/W2034630057","https://openalex.org/W2036034164","https://openalex.org/W2038523067","https://openalex.org/W2042282560","https://openalex.org/W2048613126","https://openalex.org/W2050642572","https://openalex.org/W2056594490","https://openalex.org/W2057218988","https://openalex.org/W2057330499","https://openalex.org/W2063400466","https://openalex.org/W2070027753","https://openalex.org/W2078741112","https://openalex.org/W2085838830","https://openalex.org/W2087139433","https://openalex.org/W2092726265","https://openalex.org/W2096409056","https://openalex.org/W2097870088","https://openalex.org/W2103274121","https://openalex.org/W2105345588","https://openalex.org/W2107233004","https://openalex.org/W2110739243","https://openalex.org/W2110781127","https://openalex.org/W2112494872","https://openalex.org/W2115169717","https://openalex.org/W2127797163","https://openalex.org/W2128930711","https://openalex.org/W2134289175","https://openalex.org/W2139051356","https://openalex.org/W2146264128","https://openalex.org/W2147663252","https://openalex.org/W2148850438","https://openalex.org/W2150012656","https://openalex.org/W2150959326","https://openalex.org/W2153314625","https://openalex.org/W2156184287","https://openalex.org/W2158666727","https://openalex.org/W2159969745","https://openalex.org/W2166855581","https://openalex.org/W2167388722","https://openalex.org/W2168543332","https://openalex.org/W2171294019","https://openalex.org/W2242187146","https://openalex.org/W2264045234","https://openalex.org/W2274836352","https://openalex.org/W2306356166","https://openalex.org/W2397512443","https://openalex.org/W2425644022","https://openalex.org/W2433275654","https://openalex.org/W2444268874","https://openalex.org/W2519510391","https://openalex.org/W2542709139","https://openalex.org/W2550011910","https://openalex.org/W2558288750","https://openalex.org/W2566015011","https://openalex.org/W2569337371","https://openalex.org/W2596179513","https://openalex.org/W2613443288","https://openalex.org/W2626446274","https://openalex.org/W2626992208","https://openalex.org/W2740125859","https://openalex.org/W2740802742","https://openalex.org/W2754041380","https://openalex.org/W2766931456","https://openalex.org/W2766969102","https://openalex.org/W2799777685","https://openalex.org/W2883554163","https://openalex.org/W2888743963","https://openalex.org/W2894746763","https://openalex.org/W2899997727","https://openalex.org/W2901979245","https://openalex.org/W2903149964","https://openalex.org/W2906936416","https://openalex.org/W2922829459","https://openalex.org/W2937621834","https://openalex.org/W2939222610","https://openalex.org/W2948612418","https://openalex.org/W2951020124","https://openalex.org/W2952294061","https://openalex.org/W2953188769","https://openalex.org/W2955099619","https://openalex.org/W2966389726","https://openalex.org/W2970797239","https://openalex.org/W2971288779","https://openalex.org/W2972869264","https://openalex.org/W3011554503","https://openalex.org/W3011587204","https://openalex.org/W3014025744","https://openalex.org/W3024089600","https://openalex.org/W3031047464","https://openalex.org/W3080429667","https://openalex.org/W3083330516","https://openalex.org/W3087136340","https://openalex.org/W3093042356","https://openalex.org/W3100327816","https://openalex.org/W3101044784","https://openalex.org/W3132991472","https://openalex.org/W3174527743","https://openalex.org/W3179956646","https://openalex.org/W3191267295","https://openalex.org/W3193467790","https://openalex.org/W4213096040","https://openalex.org/W4283765641","https://openalex.org/W4297021616","https://openalex.org/W4306247155","https://openalex.org/W4321783346","https://openalex.org/W4377157780","https://openalex.org/W4378071807","https://openalex.org/W4386151915","https://openalex.org/W4386858142"],"related_works":["https://openalex.org/W2905322153","https://openalex.org/W2949753825","https://openalex.org/W2183849699","https://openalex.org/W2793091660","https://openalex.org/W2102467882","https://openalex.org/W1965682163","https://openalex.org/W2042645750","https://openalex.org/W2030484664","https://openalex.org/W4385609776"],"abstract_inverted_index":{"Background:":[0],"Hyperglycemia,":[1],"insulin":[2],"resistance,":[3],"and":[4,20,61,117,129,141,171,197,218,266,277,328,369,386,574,607],"the":[5,21,25,66,114,126,159,168,177,186,198,273,301,305,326,370,381,393,400,451],"presence":[6],"of":[7,15,44,56,68,85,94,97,123,131,134,161,165,188,200,275,307,340,359,383,412,419,431,437,453,462,524,561],"advanced":[8],"glycation":[9],"end":[10],"products":[11],"are":[12],"key":[13],"features":[14],"type":[16,490,533,613],"2":[17,491,534,614],"diabetes":[18,50,567],"(T2DM)":[19],"leading":[22],"mechanisms":[23,128],"behind":[24],"increased":[26],"cardiovascular":[27],"risk":[28,43,55,96,358,382,436,452],"observed":[29,324],"in":[30,47,71,100,203,243,252,258,282,319,331,353,373,389,440,489,500,530,564,610],"people":[31,48],"with":[32,41,49,92,102,105,121,149,163,205,210,224,237,241,290,350,367,391,395,450,502,532,566,569,612],"this":[33,132],"condition.":[34],"Percutaneous":[35],"coronary":[36,206,527],"revascularization":[37],"has":[38],"been":[39],"associated":[40,120,449],"higher":[42],"stent":[45,62,72,194,214,269,360,384,438,454,562,608],"failure":[46,73,361,385,421,439,488,563,609],"mellitus":[51],"(DM),":[52],"having":[53],"greater":[54],"both":[57,151,499],"in-stent":[58],"restenosis":[59],"(ISR)":[60],"thrombosis":[63],"(ST).":[64],"Moreover,":[65],"role":[67],"glycemic":[69,308,387,397,447],"control":[70,309,371,388,398,448,606],"outcomes":[74],"is":[75,405],"uncertain.":[76],"Glucagon-like":[77],"pepetide-1":[78],"receptor":[79,572],"(GLP-1R)":[80],"agonists":[81,573],"(GLP-1RA),":[82],"a":[83,211,254,291,504,536,616],"family":[84],"glucose-lowering":[86],"agents,":[87],"have":[88,109],"demonstrated":[89],"cardioprotective":[90],"actions":[91,130],"reductions":[93],"relative":[95],"about":[98],"16%":[99],"subjects":[101,148,251,493,531,611],"T2DM":[103,250],"compared":[104,158,349],"placebo.":[106],"Preclinical":[107],"data":[108,225],"indicated":[110],"beneficial":[111,410],"effects":[112,160,187,411],"on":[113,167,193,337,414,485,494,526],"cardiac":[115,173,415],"function":[116,416],"vascular":[118],"healing":[119],"activation":[122],"GLP-1R.":[124],"However,":[125],"specific":[127],"class":[133],"drugs":[135],"remain":[136],"unexplored.":[137],"Methods:":[138],"Studies":[139,216,264,442],"I":[140,157],"II":[142,184,443],"were":[143,220,323],"randomized":[144,505,537],"clinical":[145],"trials":[146],"including":[147],"T2DM,":[150,392],"open":[152,506],"label":[153],"but":[154],"assessor-blinded.":[155],"Study":[156,183,232,246,283,299,332,354,374],"liraglutide":[162,327,495],"those":[164,365],"glimepiride":[166,329,498],"subclinical":[169,486],"systolic":[170],"diastolic":[172],"function,":[174],"represented":[175],"by":[176,310,457],"longitudinal":[178],"functional":[179],"reserve":[180],"index":[181],"(LFRI).":[182],"studied":[185],"exenatide":[189,348,525],"over":[190],"standard":[191,351],"treatment":[192,289,352,425,496],"strut":[195],"coverage":[196],"extent":[199],"neointima":[201,343],"hyperplasia":[202],"participants":[204],"artery":[207],"disease":[208],"revascularized":[209,239],"contemporary":[212],"drug-eluting":[213],"(DES).":[215],"III":[217,233,265,284],"IV":[219,247,267],"observational,":[221],"retrospective":[222],"studies":[223],"derived":[226],"from":[227],"several":[228],"Swedish":[229],"national":[230],"registers.":[231],"included":[234],"all":[235],"patients":[236,565],"DM":[238],"percutaneously":[240],"DES":[242,255,341],"2007-2017,":[244],"whereas":[245],"comprised":[248],"only":[249],"whom":[253],"was":[256,268,285,304,345,362,378],"implanted":[257],"2010-2020.":[259],"The":[260,279,540],"primary":[261],"endpoint":[262],"for":[263,347,364,409],"failure,":[270,455],"defined":[271],"as":[272],"occurrence":[274],"ISR":[276,458],"ST.":[278],"exposure":[280,302],"variable":[281,303],"incretin":[286],"treatment,":[287],"i.e.,":[288],"GLP-1RA":[292,413,424],"or":[293,321,342,434,444],"dipeptidyl":[294,575],"peptidase":[295],"4":[296],"inhibitor.":[297],"In":[298],"IV,":[300],"level":[306],"stratified":[311],"glycated":[312],"hemoglobin":[313],"A1c":[314],"levels.":[315],"Results:":[316],"No":[317,334],"differences":[318],"LFRIsystolic":[320],"LFRIdiastolic":[322],"between":[325,380],"groups":[330],"I.":[333,465],"significant":[335],"effect":[336],"improved":[338,432],"endothelialization":[339,433,529],"thickness":[344],"found":[346,379],"II.":[355,514],"A":[356,578],"similar":[357],"detected":[363],"treated":[366,568],"incretins":[368],"group":[372],"III.":[375,445,547],"An":[376],"association":[377],"persons":[390],"subgroups":[394],"worse":[396],"exhibiting":[399],"highest":[401],"risk.":[402],"Conclusions:":[403],"There":[404],"no":[406],"compelling":[407],"evidence":[408],"and/or":[417],"improvement":[418],"heart":[420,487],"(Study":[422,459],"I).":[423],"did":[426],"not":[427],"show":[428],"any":[429],"signs":[430],"reduced":[435],"either":[441],"Poor":[446],"driven":[456],"IV).":[460],"List":[461],"scientific":[463],"papers":[464],"Nystr\u00f6m":[466,521,558,603],"T,":[467],"Santos-Pardo":[468,548,588],"I,":[469,516,549,589],"Hedberg":[470],"F,":[471],"Wardell":[472],"J,":[473],"Witt":[474,517,554,599],"N,":[475,518,555,600],"Cao":[476],"Y,":[477],"Boj\u00f6":[478],"L,":[479],"Nilsson":[480],"B,":[481,551,594,598],"Jendle":[482],"J.":[483],"Effects":[484,523],"diabetic":[492],"vs.":[497],"combination":[501],"metformin:":[503],"parallel-group":[507],"study.":[508,542,581,619],"Front":[509],"Endocrinol":[510],"(Lausanne).":[511],"2017;8:325.":[512],"https://doi.org/10.3389/fendo.2017.00325":[513],"Santos-Pardo,":[515],"Anger\u00e5s":[519],"O,":[520],"T.":[522,559,604],"stent\u2019s":[528],"diabetes:":[535,615],"controlled":[538],"trial.":[539],"Rebuild":[541],"Cardiovasc":[543],"Diabetol.":[544],"2023;22(1):337.":[545],"https://doi.org/10.1186/s12933-023-02071-4":[546],"Lagerqvist":[550,593],"Ritsinger":[552,595],"V,":[553,596],"Norhammar":[556,601],"A,":[557,602],"Risk":[560],"glucagon-like":[570],"peptide-1":[571],"peptidase-4":[576],"inhibitors:":[577],"nationwide":[579,617],"observational":[580,618],"Int":[582],"J":[583],"Cardiol.":[584],"2021;330:23-9.":[585],"https://doi.org/10.1016/j.ijcard.2021.02.011":[586],"IV.":[587],"Andersson":[590],"Franko":[591],"M,":[592],"Eliasson":[597],"Glycemic":[605],"[Submitted]":[620]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7017744282","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2025-10-10T00:00:00"}
